Suppr超能文献

肺移植候选者的细胞因子、骨转换标志物及体重变化

Cytokines, bone turnover markers and weight change in candidates for lung transplantation.

作者信息

Førli L, Mellbye O J, Halse J, Bjørtuft O, Vatn M, Boe J

机构信息

Department of Medicine, Rikshospitalet, University of Oslo, N-0027 Oslo, Norway.

出版信息

Pulm Pharmacol Ther. 2008;21(1):188-95. doi: 10.1016/j.pupt.2007.02.002. Epub 2007 Feb 24.

Abstract

Weight loss in chronic obstructive pulmonary disease (COPD) is associated with increased morbidity and may negatively affect bone mineral density. Increased serum levels of cytokines such as tumour necrosis factor (TNF)-alpha have been associated with weight loss and with bone resorption. We studied the association between systemic inflammation, markers for bone turnover and recent weight change in underweight (n=48) and normal-weight patients (n=23) candidates for lung transplantation where the majority (56%) had COPD. Osteoporosis or osteopenia was present in all the diagnostic groups. The resulting model of linear regression in COPD patients showed that for the 1-CTP (a marker of bone resorption) model, the total variation of 61% was explained by recent weight change, sTNF-alpha receptor(R)II, dose of prednisolon and age. The resulting model of linear regression in the whole group of patients showed that the total variation of 72% was explained by recent weight change, sTNF-alpha RI, diagnosis (COPD/other diagnosis), dose of prednisolon and C-reactive protein. In conclusion, our results showed that serum concentration of 1-CTP was positively associated with sTNF-alpha receptor II and negatively with recent weight change in patients with advanced COPD. Recent weight loss in both the underweight and normal-weight patients showed to be a more important contributor than recent weight loss only in underweight patients for explaining variations in 1-CTP.

摘要

慢性阻塞性肺疾病(COPD)患者体重减轻与发病率增加相关,且可能对骨密度产生负面影响。血清中肿瘤坏死因子(TNF)-α等细胞因子水平升高与体重减轻及骨吸收有关。我们研究了全身炎症、骨转换标志物与近期体重变化之间的关联,研究对象为体重过轻(n = 48)和体重正常(n = 23)的肺移植候选患者,其中大多数(56%)患有COPD。所有诊断组均存在骨质疏松或骨质减少。在COPD患者中得到的线性回归模型显示,对于1-CTP(骨吸收标志物)模型,61%的总变异可由近期体重变化、可溶性TNF-α受体(R)II、泼尼松龙剂量和年龄解释。在所有患者组中得到的线性回归模型显示,72%的总变异可由近期体重变化、可溶性TNF-α RI、诊断(COPD/其他诊断)、泼尼松龙剂量和C反应蛋白解释。总之,我们的结果表明,在晚期COPD患者中,血清1-CTP浓度与可溶性TNF-α受体II呈正相关,与近期体重变化呈负相关。体重过轻和体重正常患者近期体重减轻对解释1-CTP变化而言,比仅体重过轻患者近期体重减轻是更重要的因素。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验